Sort
17,288 grants matching “multiple sclerosis”
Effects of Re-expression of Motor Neuron Selector Transcription Factors on ALS Pathology
$645,391Hynek Wichterle · Columbia University Health Sciences · R01 · FY2025 · NS
MR Metabolic Imaging of Multiple Sclerosis
$645,373Jeremy William Gordon · University Of California, San Francisco · R01 · FY2023 · NS
Novel Traffic-targeted Therapies for IBD
$645,373Jesus Rivera-Nieves · University Of California, San Diego · R01 · FY2018 · DK
Novel Traffic-targeted Therapies for IBD
$645,373Jesus Rivera-Nieves · University Of California, San Diego · R01 · FY2017 · DK
Mechanisms of cardiac sympathetic hyperactivity in chronic heart failure
$645,067Yu-Long Li · University Of Nebraska Medical Center · R01 · FY2025 · HL
Investigation of THC Receptors
$644,804Jenny L. Wiley · Research Triangle Institute · R01 · FY2014 · DA
Quality of Life for SCI Clinical Trials: Development of the SCI-QOL
$644,695David Scott Tulsky · Kessler Foundation, Inc. · R01 · FY2007 · HD
A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy
$644,322Gerald V Raymond · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2009 · HD
Targeting TGFb/IFNy-IRF8 Signaling to Modulate Monocytes and their Crosstalk with Microglia and Astrocytes to Treat Multiple Sclerosis
$644,207Oleg Butovsky · Brigham And Women'S Hospital · R01 · FY2025 · NS
Temporal relation discovery for clinical text
$643,863Guergana K. Savova · Boston Children'S Hospital · R01 · FY2016 · LM
Neuroprotection by IFN-beta in AIDS
$643,693Marcus Kaul · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · MH
Temporal relation discovery for clinical text
$643,621Guergana K. Savova · Boston Children'S Hospital · R01 · FY2017 · LM
The role of mTOR signaling in oligodendrocyte differentiation and CNS myelination
$643,464Wendy B Macklin · University Of Colorado Denver · R01 · FY2016 · NS
Host's and microbiota's contribution to sexual dimorphism of autoimmunity
$643,338Alexander V Chervonsky · University Of Chicago · R01 · FY2025 · AI
MRI predictors of disease and disability progression in African Americans with multiple sclerosis
$643,285Fred D Lublin · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
A Whole Genome Admixture Scan for Multiple Sclerosis
$643,266Harvard University (Medical School) · R01 · FY2004 · NS
Novel Strategies to Identify GxE Contributions to MS Pathogenesis
$643,215Lisa F Barcellos · University Of California Berkeley · R01 · FY2011 · ES
Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing
$643,211Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · U01 · FY2020 · DA
Identification of REV-ERB inverse agonists for cancer immunotherapy
$643,014Laura A Solt · Scripps Florida · R01 · FY2020 · CA
KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions
$642,896Emmanuel J Mignot · Stanford University · U01 · FY2022 · NS
Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome
$642,750Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
SPEECH MOVEMENT CLASSIFICATION FOR ASSESSING AND TREATING ALS
$642,629Jordan R Green · Mgh Institute Of Health Professions · R01 · FY2014 · DC
A Vascularized Micro-Organ platform for the study of Brain-BBB-Blood interaction
$642,429Christopher C. W. Hughes · University Of California-Irvine · R61 · FY2021 · HL
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
$642,410Arlene H Sharpe · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$641,790Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS